• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Refined risk stratification in pulmonary arterial hypertension and timing of lung transplantation.

作者信息

Olsson Karen M, Richter Manuel J, Kamp Jan C, Gall Henning, Ghofrani Hossein-Ardeshir, Fuge Jan, Ewert Ralf, Hoeper Marius M

机构信息

Dept of Pneumology, Hannover Medical School, Member of the German Center for Lung Research (DZL), Hannover, Germany

Dept of Pneumology, Kerckhoff Heart, Rheuma and Thoracic Center, Bad Nauheim, Germany.

出版信息

Eur Respir J. 2022 Aug 4;60(2). doi: 10.1183/13993003.03087-2021. Print 2022 Aug.

DOI:10.1183/13993003.03087-2021
PMID:35144993
Abstract
摘要

相似文献

1
Refined risk stratification in pulmonary arterial hypertension and timing of lung transplantation.肺动脉高压的精细风险分层与肺移植时机
Eur Respir J. 2022 Aug 4;60(2). doi: 10.1183/13993003.03087-2021. Print 2022 Aug.
2
Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation.肺移植治疗肺动脉高压患者：波兰心脏病学会肺循环工作组的意见。
Kardiol Pol. 2022;80(11):1167-1168. doi: 10.33963/KP.a2022.0248.
3
The Evolution of Risk Assessment in Pulmonary Arterial Hypertension.肺动脉高压风险评估的演变。
Methodist Debakey Cardiovasc J. 2021 Jul 1;17(2):134-144. doi: 10.14797/LRPR7655. eCollection 2021.
4
Commentary: Will the reversed Potts shunt replace lung transplantation for children with end-stage pulmonary arterial hypertension?述评：反向Potts分流术会取代终末期肺动脉高压患儿的肺移植吗？
J Thorac Cardiovasc Surg. 2021 Mar;161(3):1150-1151. doi: 10.1016/j.jtcvs.2020.11.024. Epub 2020 Nov 19.
5
Lung Transplantation for Pulmonary Arterial Hypertension.用于肺动脉高压的肺移植
Chest. 2023 Oct;164(4):992-1006. doi: 10.1016/j.chest.2023.04.047. Epub 2023 May 5.
6
The Pursuit of Risk Assessment and Stratification Tools in Pulmonary Arterial Hypertension: Have We Seen the Lite?肺动脉高压风险评估与分层工具的探索：我们看到曙光了吗？
Chest. 2021 Jan;159(1):14-16. doi: 10.1016/j.chest.2020.10.026.
7
Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.肺动脉高压的风险分层：不要忘记患者的视角。
Am J Respir Crit Care Med. 2021 Mar 15;203(6):675-677. doi: 10.1164/rccm.202012-4350ED.
8
Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.ESC/ERS 4 分层风险分层模型在肺动脉高压伴变量缺失时的表现。
Eur Respir J. 2023 Nov 29;62(5). doi: 10.1183/13993003.01023-2023. Print 2023 Nov.
9
Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?肺动脉高压的风险分层：或许简单并非最佳？
Chest. 2024 Feb;165(2):431-436. doi: 10.1016/j.chest.2023.09.005. Epub 2023 Sep 12.
10
The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.拟议的风险分层工具在儿童肺动脉高压中的临床价值
Am J Respir Crit Care Med. 2019 Nov 15;200(10):1312-1315. doi: 10.1164/rccm.201902-0266LE.

引用本文的文献

1
Prognostic value of cardiopulmonary exercise testing in pulmonary arterial hypertension.心肺运动试验在肺动脉高压中的预后价值
Eur Respir J. 2025 Aug 22;66(2). doi: 10.1183/13993003.02026-2024. Print 2025 Aug.
2
[Lung involvement in connective tissue diseases].[结缔组织病中的肺部受累]
Z Rheumatol. 2025 Apr;84(3):198-209. doi: 10.1007/s00393-025-01635-x.
3
Risk stratification and treatment goals in pulmonary arterial hypertension.肺动脉高压的风险分层和治疗目标。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01323-2024. Print 2024 Oct.
4
Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review.连续风险分层对成人和儿科肺动脉高压的预后价值：系统评价。
J Am Heart Assoc. 2024 Jul 2;13(13):e034151. doi: 10.1161/JAHA.123.034151. Epub 2024 Jun 21.
5
Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH).人口健康模型预测 Sotatercept 对肺动脉高压（PAH）患者发病率和死亡率的长期影响。
Adv Ther. 2024 Jan;41(1):130-151. doi: 10.1007/s12325-023-02684-x. Epub 2023 Oct 18.
6
Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertension.肺动脉高压常规无创随访评估中识别出的残余风险。
ERJ Open Res. 2023 May 30;9(3). doi: 10.1183/23120541.00072-2023. eCollection 2023 May.